| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.92T | 2.16T | 2.32T | 2.55T | 2.50T | 2.43T |
| Gross Profit | 417.25B | 457.06B | 401.22B | 392.53B | 496.31B | 487.14B |
| EBITDA | 85.89B | 77.40B | 40.84B | 60.65B | 159.18B | 156.73B |
| Net Income | 107.20B | 36.09B | -149.98B | -260.84B | 73.99B | 53.26B |
Balance Sheet | ||||||
| Total Assets | 1.44T | 1.45T | 1.59T | 1.77T | 1.96T | 1.93T |
| Cash, Cash Equivalents and Short-Term Investments | 241.79B | 279.31B | 227.13B | 262.06B | 287.36B | 341.92B |
| Total Debt | 448.97B | 547.04B | 597.71B | 735.67B | 633.76B | 733.58B |
| Total Liabilities | 1.17T | 1.29T | 1.43T | 1.55T | 1.49T | 1.56T |
| Stockholders Equity | 258.02B | 154.65B | 143.18B | 208.74B | 454.57B | 350.65B |
Cash Flow | ||||||
| Free Cash Flow | -51.21B | -28.39B | 83.62B | -28.82B | 27.57B | 168.99B |
| Operating Cash Flow | -29.53B | -1.59B | 124.50B | 14.75B | 75.16B | 204.64B |
| Investing Cash Flow | 157.18B | 103.74B | 10.88B | -40.97B | -31.45B | -14.11B |
| Financing Cash Flow | -133.22B | -74.77B | -149.67B | -18.48B | -124.29B | -76.72B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥377.09B | 9.83 | 5.53% | 3.55% | -5.43% | 55.21% | |
66 Neutral | ¥184.23B | 8.81 | 13.53% | 1.34% | 0.48% | -1.86% | |
64 Neutral | ¥3.63T | 17.73 | 1.37% | 2.29% | -0.51% | -45.68% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | ¥6.68T | -69.04 | 4.25% | 1.99% | -6.96% | -7.22% | |
56 Neutral | ¥20.32T | -5.95 | 14.45% | 0.55% | -2.86% | 5.93% | |
49 Neutral | ¥392.41B | 5.68 | ― | ― | -10.88% | ― |